CBO Overestimates Costs Of Enforcing DXM Sales Age-Restriction – CHPA

CHPA says CBO's five-year $232m estimate for the costs of compliance with the DXM Abuse Prevention Act is too high since it is based on costs of FDA's tobacco compliance check program. CBO says the bill would have a minimal cost impact on retailers, since many already restrict sales.